William Richards
Clinical Psychologist and Psychedelic Researcher
Data updated
Research Footprint
William Richards appears in 16 tracked papers (1972–2026), most studied alongside Psilocybin, LSD and DMT, across Anxiety Disorders, Depressive Disorders and Palliative & End-of-Life Distress.
Most-cited paper: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (1671 citations).
Frequent co-authors: Roland Griffiths, Matthew Johnson and Robert Jesse.
Background & Research
William A. Richards is a clinical psychologist whose research career spans the original era of LSD psychotherapy and the contemporary renaissance in psychedelic clinical science. In the late 1960s and early 1970s he published influential clinical reports on LSD-assisted psychotherapy for patients confronting terminal illness and on adjunctive use of dissociative agents in addiction treatment, collaborating with colleagues such as Stanislav Grof. In subsequent decades he has continued to shape the field through empirical and methodological work on the psychospiritual effects of classic psychedelics, including controlled investigations of psilocybin's effects on religious and spiritual attitudes and behaviour.
In the 2000s and 2010s Richards contributed to the codification of safety and ethical guidelines for human hallucinogen research and authored the book Sacred Knowledge, which synthesises decades of clinical observations about psychedelics and religious experience. More recently he has been involved in developing and evaluating therapist training programmes and clinical protocols for psilocybin-assisted therapy in mood disorders, helping to translate historical clinical practice into standards for modern, regulated clinical trials. His work emphasises rigorous clinical care, integration, and the assessment of lasting psychological and existential outcomes following psychedelic-assisted interventions.
Key Impact
A seminal clinician–researcher whose work bridges early LSD-assisted psychotherapy with contemporary psilocybin trials, therapist training, and systematic study of the spiritual and end-of-life dimensions of psychedelic therapy.
Collaboration Network
25 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations William Richards is associated with.
Johns Hopkins University
academicThe Centre for Psychedelic and Consciousness Research focuses on how psychedelics affect behavior, cognition, brain function, and biological health markers. They have been at the forefront of demonstrating the safety and efficacy of psychedelics for mental disorders, expanding their focus into psilocybin research across multiple mental health conditions, including smoking cessation, major depressive disorder, and cancer-related anxiety.
View stakeholder →Sunstone Therapies
A U.S. clinical research and care organization focused on psychedelic-assisted therapy delivery in structured clinical settings.
View stakeholder →